Tag: VIVA
BOLT-DVT records complete or near-complete thrombus reduction in 98% of patients
Patrick Muck (Good Samaritan Hospital, Cincinnati, USA) speaks to Venous News at The VEINS 2026 (3–4 October, Las Vegas, USA) after presenting the primary...
Societies seek consensus on NIVL management amid “paucity of rigorous data”
The diagnosis and management of non-thrombotic iliac vein lesions (NIVL) is the focus of a newly published set of consensus statements from the Vascular...
Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid,...
Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...
Six-month outcomes from phase-one trial of anti-inflammatory drug to assess benefit...
The open-label phase of the DEXTERITY-AFP trial investigating the Bullfrog microinfusion device—which involves the perivenous injection of the anti-inflammatory drug dexamethasone to improve patency...
First look at CLOUT registry reveals over 75% of DVT patients...
David J. Dexter, (Sentara Healthcare, Norfolk, VA, USA), principal investigator of the CLOUT registry using the ClotTriever Mechanical Thrombectomy System (Inari Medical) for treatment...